Form 4: Roivant Sciences Director Sells Shares
Insider Transaction (Form 4)
Meghan Fitzgerald, a Director of Roivant Sciences Ltd., sold 5,112 shares of common stock on September 15, 2026.
Summary
- Open-market sale: disposed of 4,712 Common Shares at $39.68 ($186,972) on September 15, 2026; holds 36,508 after (Direct).
- Open-market sale: disposed of 400 Common Shares at $40.45 ($16,180) on September 15, 2026; holds 36,108 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $203,152 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Meghan Fitzgerald — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-15 | Open-market sale | Common Shares | 4,712 | $40 | $187.0K | 36,508 |
| 2026-09-15 | Open-market sale | Common Shares | 400 | $40 | $16.2K | 36,108 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-15 | Open-market sale (4,712 shares) |
| 2026-09-15 | Open-market sale (400 shares) |
Keywords
insider transaction, Form 4, ROIV, Roivant Sciences Ltd., bearish, Meghan Fitzgerald
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.